生物相容性
内耳
体内
生物相容性材料
离体
氧化铁纳米粒子
磁性纳米粒子
生物医学工程
纳米技术
人口
药物输送
纳米颗粒
药理学
医学
化学
材料科学
生物
生物技术
环境卫生
有机化学
放射科
作者
María Julia Martín,M. Schneider,Giuliana Paolillo,F. H. Sánchez,Marcos J. Lo Fiego,Guillermo Spitzmaul,Verónica Lassalle
出处
期刊:ChemMedChem
[Wiley]
日期:2024-08-01
卷期号:19 (22): e202400321-e202400321
被引量:5
标识
DOI:10.1002/cmdc.202400321
摘要
Hearing loss (HL) affects more than 5 % of the global population, with projections indicating an impact of up to 50 % on young individuals in the next years. HL treatments remain limited due to the inner ear's hermeticism. HL often involves inflammatory processes, underscoring the need for enhanced delivery of antiinflammatory agents to the inner ear. Our research focuses on the development of a directed therapy based on magnetic nanoparticles (MNPs). We previously synthesized biocompatible folic acid-coated iron oxide-core nanoparticles (MNPs@FA) as potential carriers for the anti-inflammatory Diclofenac (Dfc). This study aims to incorporate Dfc onto MNPs@FA to facilitate targeted drug delivery to the inner ear. Through optimizing the loading procedure, we achieved optimal loading capacity. Dfc release was studied in the simulated target fluid and the administration vehicle. Complete characterization is also shown. In vitro biocompatibility testing ensured the biosafety of the resulting formulation. Subsequent ex vivo targeting assays on murine cochleae validated the nanosystems' ability to penetrate the round window membrane, one of the main HL therapy barriers. These findings serve as validation before continuing to more complex in vivo studies. Together, the data here presented represent an advancement in addressing unmet medical needs in HL therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI